Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Jun Hozumi"'
Autor:
Yaeko Yokoshima, Masahiko Sumitani, Daisuke Nishizawa, Makoto Nagashima, Kazutaka Ikeda, Ryoji Kato, Jun Hozumi, Hiroaki Abe, Kenji Azuma, Rikuhei Tsuchida, Yoshitsugu Yamada, Japanese TR‐Cancer Pain Research Group
Publikováno v:
Neuropsychopharmacology Reports, Vol 38, Iss 4, Pp 175-181 (2018)
Abstract Aim Cancer pain impairs not only physical functions but also social functions and roles. Consequently, the overall health‐related quality of life of patients with cancer pain deteriorates. Opioid analgesics are recommended for treating mod
Externí odkaz:
https://doaj.org/article/239702f437894a6397ce460e3e2f3701
Autor:
Jun Hozumi, Masahiko Sumitani, Yoshitaka Matsubayashi, Hiroaki Abe, Yasushi Oshima, Hirotaka Chikuda, Katsushi Takeshita, Yoshitsugu Yamada
Publikováno v:
Pain Research and Management, Vol 2016 (2016)
Objectives. Overweight negatively affects musculoskeletal health; hence obesity is considered a risk factor for osteoarthritis and chronic low back pain. This was conducted to determine if obesity affects neuropathic pain, usually considered unrelate
Externí odkaz:
https://doaj.org/article/6ee572f16a994d92a2e66d0b7e419b9c
Autor:
Jun Hozumi, Masahiko Sumitani, Arito Yozu, Toshiya Tomioka, Hiroshi Sekiyama, Satoru Miyauchi, Yoshitsugu Yamada
Publikováno v:
Anesthesiology Research and Practice, Vol 2011 (2011)
Neural blockades are considered an alternative to pharmacotherapy for neuropathic pain although these blockades elicit limited effects. We encountered a patient with postbrachial plexus avulsion injury pain, which was refractory to conventional treat
Externí odkaz:
https://doaj.org/article/f2b19d5c79e64e1abeab78e53cf78de3
Autor:
Kenji Azuma, Kosuke Saita, Rikuhei Tsuchida, Jun Hozumi, Hiroaki Abe, Reo Inoue, Masahiko Sumitani, Masae Ando, Mitsuru Konishi
Publikováno v:
JMA Journal
Introduction Opioid analgesics are the mainstay of cancer pain management. The annual opioid consumption globally indicates adequate opioid availability and the quality of palliative care. We investigated the current situation regarding the adequacy
Autor:
Masahiko Sumitani, Jun Hozumi, Kenji Ino, Mitsuru Konishi, Reo Inoue, Kenji Azuma, Hiroaki Abe, Rikuhei Tsuchida
Publikováno v:
Regional Anesthesia & Pain Medicine. 45:757-760
Spinal muscular atrophy (SMA) is an autosomal recessive hereditary neurodegenerative disease causing progressive muscle atrophy, weakness and kyphoscoliosis. Nusinersen is a therapeutic agent for SMA that should be administered intrathecally. However
Autor:
Hiroaki Abe, Rikuhei Tsuchida, Masahiko Sumitani, Yasushi Oshima, Yoshitsugu Yamada, Kenji Azuma, Shuichi Katano, Jun Hozumi, Reo Inoue
Publikováno v:
Pain Practice. 20:34-43
Background Lumbar adhesive arachnoiditis is a debilitating neuropathic condition and is difficult to diagnose owing to lack of definitive diagnostic criteria. By focusing on the intrathecal mobility of nerve roots, we assessed whether useful diagnost
Autor:
Jun, Hozumi
学位の種別: 課程博士
審査委員会委員 : (主査)東京大学教授 松尾 豊, 東京大学教授 坂田 一郎, 東京大学准教授 武田 史子, 東京大学准教授 田中 謙司, 東京大学准教授 鳥海 不二夫
審査委員会委員 : (主査)東京大学教授 松尾 豊, 東京大学教授 坂田 一郎, 東京大学准教授 武田 史子, 東京大学准教授 田中 謙司, 東京大学准教授 鳥海 不二夫
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::1dfe061c533b6d57df31486931ebb349
https://repository.dl.itc.u-tokyo.ac.jp/records/2006857
https://repository.dl.itc.u-tokyo.ac.jp/records/2006857
Publikováno v:
Journal of neuroscience researchREFERENCES. 100(1)
The prevalence of cancer-related pain is 64% among patients with metastatic, advanced, or terminal cancer, 59% among patients undergoing anticancer treatment, and 33% among patients who completed curative treatment. According to the World Health Orga
Autor:
Rikuhei Tsuchida, Kazutaka Ikeda, Jun Hozumi, Makoto Nagashima, Kenji Azuma, Masahiko Sumitani, Yaeko Yokoshima, Yoshitsugu Yamada, Hiroaki Abe, Ryoji Kato, Daisuke Nishizawa
Publikováno v:
Neuropsychopharmacology Reports
Aim Cancer pain impairs not only physical functions but also social functions and roles. Consequently, the overall health‐related quality of life of patients with cancer pain deteriorates. Opioid analgesics are recommended for treating moderate to